Molecular analysis of BRCA1 founder mutations among 2546 unselected breast cancer patients has revealed the presence of mutations in 96 (3.77%) cases, including 25 (0.98%) c.4034delA mutations and 69 (2.70%) c.5266dupC mutations. This evidence concerns the gene BRCA1 and breast cancer.